The 13D Report
The 13D Report
Shareholder activism
⌘K
Signup free
activistletters

Findell Capital Escalates Proxy Fight at Oportun (OPRT) as Founder Gutierrez Slams Governance, Urges Shareholders to Support Board Refresh

Summary

Findell Capital’s June 23, 2025 presentation pushes back against Oportun’s defense, stressing that founder James Gutierrez endorsed their plan, supported Warren Wilcox for the board, and called for removing the 36% rate cap. Findell argues that legacy directors entrenched themselves by ousting Scott Parker, the board’s best-performing member with lending expertise, while spending millions on a proxy fight. They maintain that Oportun’s cost cuts and credit improvements only followed their involvement, and that peers like OMF and RM have performed far better. Framing the contest as essential for accountability rather than control, Findell urges shareholders to elect Wilcox to bring true lending expertise and restore oversight.

Company Name: Oportun Financial Corp
Symbol: OPRT
Filing Date: Jun-23-2025
Filer Name: Findell Capital Management LLC

Download Presentation
Findell-Oportun-Jun-23-2025.pdf
3 MB
download-circle

Source:

https://www.sec.gov/Archives/edgar/data/1538716/000092189525001826/ex991dfan14a13982002_062325.pdf

Member discussion

More like this

STAAR Surgical (STAA): Broadwood Partners Urges Shareholders to Reject Alcon Merger Over Governance and Valuation Concerns

Summary Broadwood Partners’ presentation argues that STAAR Surgical’s sale to Alcon is ill-timed, flawed, and undervalued. It claims STAAR’

Khrom Capital Pushes Acadia Healthcare (ACHC) Board to Pursue Sale, Slams Entrenched Leadership and Poor Capital Allocation

Summary Khrom Capital, owning 5.5% of Acadia Healthcare, criticized the company’s decade-long underperformance, poor capital allocation, and entrenched

STAAR Surgical (STAA): Broadwood Capital Urges Shareholders to Reject Alcon Merger, Highlighting Governance Conflicts and Poor Timing

Summary Broadwood Capital, owning 27.5% of STAAR Surgical, urged shareholders to vote against the proposed $28-per-share sale to Alcon,

Al Hartman Presses Silver Star Properties REIT (SLVS) Holders: Reject Current Board, Back Liquidation Plan Amid Alleged Misconduct and Value Destruction

Summary Al Hartman’s Hartman Shareholder Alliance urges Silver Star investors to vote the BLUE proxy as a “last chance”

Broadwood Partners Challenges STAAR Surgical (STAA) Sale to Alcon, Citing Inopportune Timing, Governance Issues, and Undervaluation

Summary Broadwood Partners, STAAR Surgical’s largest shareholder with a 27.5% stake, urged stockholders to vote against the proposed

Yunqi Capital Challenges STAAR Surgical (STAA)–Alcon Deal, Citing Undervaluation, Weak China Outlook Assumptions, and Governance Failures

Summary Yunqi Capital, a 5.1% shareholder of STAAR Surgical, announced it will vote against the company’s proposed $28